Multicenter retrospective assessment of thiazolidinedione monotherapy and combination therapy in patients with type 2 diabetes: Comparative subgroup analyses of glycemic control and blood lipid levels-Reference-Cited by-同舟云学术

Multicenter retrospective assessment of thiazolidinedione monotherapy and combination therapy in patients with type 2 diabetes: Comparative subgroup analyses of glycemic control and blood lipid levels

Published:2003-01 Issue: Volume:25 Page:B64-B80
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Olansky Leann,Marchetti Albert,Lau Helen

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference35 articles.

1. Nonhypoglycemic effects of thiazolidinediones;Parulkar;Ann Intern Med,2001

2. Thiazolidinediones: An update;Schoonjans;Lancet,2000

3. Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists;Olefsky;J Clin Invest,2000

4. Medical significance of peroxisome proliferator-activated receptors;Vamecq;Lancet,1999

5. Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis;Neve;Biochem Phannacol,2000

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors;Pharmacogenomics;2014-12

2. Type 2 Diabetes Mellitus in Children and Adolescents;Pediatrics in Review;2013-12-01

3. Type 2 Diabetes Mellitus in Children and Adolescents;Pediatrics In Review;2013-12-01

4. Emerging Therapies for Residual Risk;Reviews in Cardiovascular Medicine;2012-03-30

5. Postnatal Rosiglitazone Administration to Neonatal Rat Pups Does Not Alter the Young Adult Metabolic Phenotype;Neonatology;2012